Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbott AL, Donnan GA. Does the 'high risk' patient with asymptomatic carotid stenosis really exist? Eur J Vasc Endovasc Surg 2008;35(5):524-33. Review.
  2. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24):2560-72.
  3. Agrotis A. Simvastatin, an inhibitor of epithelial-to-mesenchymal transition in experimental atherosclerotic renovascular disease? J Hypertens 2008;26(8):1553-5.
  4. Ahrens I, Ellwanger C, Smith BK, Bassler N, Chen YC, Neudorfer I, Ludwig A, Bode C, Peter K. Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes. J Leukoc Biol 2008;83(6):1091-8.
  5. Ahrens I, Peter K. Therapeutic integrin inhibition: allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies. Thromb Haemost 2008;99(5):803-4. Comment.
  6. Ahrens I, Peter K. Humanizing mouse thrombi. Nat Biotechnol 2008;26(1):62-3. Review.
  7. Ajani AE, Reid CM, Duffy SJ, Andrianopoulos N, Lefkovits J, Black A, New G, Lew R, Shaw JA, Yan BP, Gurvitch R, Al-Fiadh A, Brennan AL, Clark DJ. Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry. Med J Aust 2008;189(8):423-8.
  8. Al Salmi I, Hoy WE, Kondalsamy-Chennakes S, Wang Z, Healy H, Shaw JE. Birth weight and stages of CKD: a case-control study in an Australian population. Am J Kidney Dis 2008;52(6):1070-8.
  9. Al Salmi I, Hoy WE, Kondalsamy-Chennakesavan S, Wang Z, Gobe GC, Barr EL, Shaw JE. Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes Care 2008;31(1):159-64.
  10. Alberti KG, Zimmet PZ. Should we dump the metabolic syndrome? No. BMJ 2008;336(7645):641.
  11. Amirahmadi F, Turnbull L, Du XJ, Graham RM, Woodcock EA. Heightened α1A-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning. Clin Sci 2008;114(2):157-64.
  12. Anderson JFI, Saling MM, Srikanth VK, Thrift AG, Donnan GA. Individuals with first-ever clinical presentation of a lacunar infarction syndrome: Is there an increased likelihood of developing mild cognitive impairment in the first 12 months after stroke? J Neuropsychol 2008;2(2):373-385.
  13. Anglesio MS, Arnold JM, George J, Tinker AV, Tothill R, Waddell N, Simms L, Locandro B, Fereday S, Traficante N, Russell P, Sharma R, Birrer MJ; AOCS Study Group, Defazio A, Chenevix-Trench G, Bowtell DD. Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Mol Cancer Res 2008;6(11):1678-90.
  14. ASDIAB Study Group, Thai AC, Mohan V, Khalid BA, Cockram CS, Pan CY, Zimmet P, Yeo JP. Islet autoimmunity status in Asians with young-onset diabetes (12-40 years): association with clinical characteristics, β cell function and cardio-metabolic risk factors. Diabetes Res Clin Pract 2008;80(2):224-30.
  15. Azarpazhooh MR, Nicol MB, Donnan GA, Dewey HM, Sturm JW, Macdonell RA, Pearce DC, Thrift AG. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke 2008;3(3):158-64.
  16. Bailie R, Si D, Connors C, Weeramanthri T, Clark L, Dowden M, O'Donohue L, Condon J, Thompson S, Clelland N, Nagel T, Gardner K, Brown A. Study protocol: Audit and Best Practice for Chronic Disease Extension (ABCDE) Project. BMC Health Serv Res 2008;8:184.
  17. Bailie RS, Si D, Dowden MC, Connors CM, O'Donoghue L, Liddle HE, Kennedy CM, Cox RJ, Burke HP, Thompson SC, Brown AD. Delivery of child health services in Indigenous communities: implications for the federal government's emergency intervention in the Northern Territory. Med J Aust 2008;188(10):615-8.
  18. Ballinger ML, Osman N, Wilks AF, Su S, Burns CJ, Bu X, Little PJ. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding. J Cardiovasc Pharmacol 2008;52(5):403-12.
  19. Barit D, Cooper ME. Diabetic patients and kidney protection: an attainable target. J Hypertens 2008;26(Suppl 2):S3-7. Review.
  20. Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C, Socratous F, Hastings J, Guo L, Wiesner G, Kaye DM, Bayles R, Schlaich MP, Lambert GW. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatr 2008;65(1):38-46.
  21. Barutta F, Pinach S, Giunti S, Vittone F, Forbes JM, Chiarle R, Arnstein M, Cavallo Perin P, Camussi G, Cooper ME, Gruden G. Heat shock protein expression in diabetic nephropathy. Am J Physiol Renal Physiol 2008;295(6):F1817-24.
  22. Bathgate RA, Lekgabe ED, McGuane JT, Su Y, Pham T, Ferraro T, Layfield S, Hannan RD, Thomas WG, Samuel CS, Du XJ.. Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis. Mol Cell Endocrinol 2008;280(1-2):30-8.
  23. Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Nalivaiko E. QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol 2008;295(3):H962-H968.
  24. Bayles RG, Dawood T, Lambert EA, Schlaich MP, Lambert GW. Elevated cardiac risk in patients with major depressive disorder. Am J Psychiatry 2008;165(1):137; author reply 137-8.
  25. Bayliss J, Maguire JA, Bailey M, Leet A, Kaye D, Richardson M, Bergin PJ, Dowling J, Thomson NM, Stein AN. Increased vascular endothelial growth factor mRNA in endomyocardial biopsies from allografts demonstrating severe acute rejection: a longitudinal study. Transpl Immunol 2008;18(3):264-74.
  26. Bernhardt J, Chitravas N, Meslo IL, Thrift AG, Indredavik B. Not all stroke units are the same: a comparison of physical activity patterns in Melbourne, Australia, and Trondheim, Norway. Stroke 2008;39(7):2059-65.
  27. Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A Very Early Rehabilitation Trial for Stroke (AVERT): phase II safety and feasibility. Stroke 2008;39(2):390-6.
  28. Berry PA, Teichtahl AJ, Galevska-Dimitrovska A, Hanna FS, Wluka AE, Wang Y, Urquhart DM, English DR, Giles GG, Cicuttini FM. Vastus medialis cross-sectional area is positively associated with patella cartilage and bone volume in a pain-free, community based population. Arthritis Res Ther 2008;10(6):R143.
  29. Bobik A. Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism. Circulation 2008;118(7):702-4. Editorial.
  30. Bolton K, Segal D, McMillan J, Jowett J, Heilbronn L, Abberton K, Zimmet P, Chisholm D, Collier G, Walder K. Decorin is a secreted protein associated with obesity and Type 2 diabetes. Int J Obes 2008;32(7):1113-21.
  31. Boyko EJ, Barr EL, Zimmet PZ, Shaw JE. Two-hour glucose predicts the development of hypertension over 5 years: the AusDiab study. J Hum Hypertens 2008;22(3):168-76.
  32. Boyko EJ, Shaw JE, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius. J Hypertens 2008;26(9):1742-9.
  33. Brooks NA, Wilcox G, Walker KZ, Ashton JF, Cox MB, Stojanovska L. Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause 2008;15(6):1157-62.
  34. Brown WA, Burton PR, Anderson M, Korin A, Dixon JB, Hebbard G, O'Brien PE. Symmetrical Pouch Dilatation After Laparoscopic Adjustable Gastric Banding: Incidence and Management. Obes Surg 2008;18(9):1104-8.
  35. Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, Harkness A, Lewis D, Littlejohn G, Miller MH, Ryan PF, Jolley D. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008;59(6):794-9.
  36. Burke SL, Evans RG, Moretti JL, Head GA. Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension. Hypertension 2008;51(4):878-83.
  37. Byrne M, Kaye DM, Power J. The synergism between atrial fibrillation and heart failure. J Card Fail 2008;14(4):320-6.
  38. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM. Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 2008;15(23):1550-7.
  39. Calkin AC, Giunti S, Sheehy KJ, Chew C, Boolell V, Rajaram YS, Cooper ME, Jandeleit-Dahm KA. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia 2008;51(9):1731-40.
  40. Calkin AC, Thomas MC. PPAR agonists and cardiovascular disease in diabetes. PPAR Res 2008;2008:245410. Review.
  41. Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, Söderberg S, Alberti KG, Tuomilehto J, Chitson P, Shaw JE. Central obesity as a precursor to the metabolic syndrome in the AusDiab Study and Mauritius. Obesity 2008;16(12):2707-2716.
  42. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, Shaw JE. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 2008;264(2):177-86.
  43. Cameron AJ, Zimmet PZ. Expanding evidence for the multiple dangers of epidemic abdominal obesity. Circulation 2008;117(13):1624-6.
  44. Campbell IG, Qiu W, Polyak K, Haviv I. Breast-cancer stromal cells with TP53 mutations. N Engl J Med 2008;358(15):1634-5; author reply 1636. \
  45. Carrington M, Murphy NF, Strange G, Peacock A, McMurray JJ, Stewart S. Prognostic impact of pulmonary arterial hypertension: a population-based analysis. Int J Cardiol 2008;124(2):183-7.
  46. Carrington M, Stewart S. Is fenofibrate a cost-saving treatment for middle-aged individuals with Type II diabetes? An economic analysis of the FIELD Study. Int J Cardiol 2008;127(1):51-6.
  47. Carrington MJ, Trinder J. Blood pressure and heart rate during continuous experimental sleep fragmentation in healthy adults. Sleep 2008;31(12):1701-1712.
  48. Chaicharn J, Carrington M, Trinder J, Khoo MC. The effects on cardiovascular autonomic control of repetitive arousal from sleep. Sleep 2008;31(1):93-103.
  49. Chalmers J, Cooper ME. UKPDS and the Legacy Effect. N Engl J Med 2008;359(15):1618-20. Editorial.
  50. Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 2008;32(4):619-28.
  51. Chen L, Rogers SL, Colagiuri S, Cadilhac DA, Mathew TH, Boyden AN, Peeters A, Magliano DJ, Shaw JE, Zimmet PZ, Tonkin AM; National Vascular Disease Prevention Alliance. How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Med J Aust 2008;189(6):319-22. Review.
  52. Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ, Horvath I, Mestril R, Watt MJ, Hooper PL, Kingwell BA, Vigh L, Hevener A, Febbraio MA. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci USA 2008;105(5):1739-44.
  53. Codyre D, Wilson A, Begg J, Barton D. Dissemination and implementation of the Royal Australian and New Zealand College of Psychiatrists' clinical practice guidelines. Australas Psychiatry 2008;16(5):336-9.
  54. Cohen ND, Dunstan DW, Robinson C, Vulikh E, Zimmet PZ, Shaw JE. Improved endothelial function following a 14-month resistance exercise training program in adults with Type 2 diabetes. Diabetes Res Clin Pract 2008;79(3):405-11.
  55. Colles SL, Dixon JB, O'Brien PE. Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity 2008;16(3):615-22.
  56. Colles SL, Dixon JB, O'Brien PE. Loss of control is central to psychological disturbance associated with binge eating disorder. Obesity 2008;16(3):608-614.
  57. Cooper ME. Oxidative stress and type 2 diabetic nephropathy. Diabetographia Med Rev 2008;19:2-4.
  58. Coughlan MT, Mibus AL, Forbes JM. Oxidative stress and advanced glycation in diabetic nephropathy. Ann N Y Acad Sci 2008;1126:190-3.
  59. Cumming TB, Collier J, Thrift AG, Bernhardt J. The effect of very early mobilisation after stroke on psychological well-being. J Rehabil Med 2008;40(8):609-14.
  60. Cunningham J, O'Dea K, Dunbar T, Weeramanthri T, Shaw J, Zimmet P. Socioeconomic status and diabetes among urban Indigenous Australians aged 15-64 years in the DRUID study. Ethn Health 2008;13(1):23-37.
  61. Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 2008;23(10):2352-8.
  62. Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle. J Biol Chem 2008;283(12):7844-52.
  63. Dadlani H, Osman N, Ballinger ML, Marasco S, Little PJ. Calcific Aortic Valve Disease and Hypertension. Curr Hypertens Rev 2008;4(2):107-113.
  64. Dart AM, Cameron JD, Gatzka C, Kingwell BA, Jennings GLR. Letter. Response to effects of angiotensin-converting enzyme inhibitors on central blood pressure. Hypertension 2008;50(3):e64:.
  65. Dart AM, Kingwell BA, Gatzka CD, Willson K, Liang YL, Berry KL, Wing LM, Reid CM, Ryan P, Beilin LJ, Jennings GL, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ, Cameron JD. Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension 2008;51(4):1129-34.
  66. Davidson PM, Driscoll A, Clark R, Newton PJ, Stewart S. Heart failure nursing in australia: challenges, strengths, and opportunities. Prog Cardiovasc Nurs 2008;23(4):195-7.
  67. Davies-Tuck ML, Wluka AE, Teichtahl AJ, Martel-Pelletier J, Pelletier JP, Jones G, Ding C, Davis SR, Cicuttini FM. Association between meniscal tears and the peak external knee adduction moment and foot rotation during level walking in postmenopausal women without knee osteoarthritis: a cross-sectional study. Arthritis Res Ther 2008;10(3):R58.
  68. Dawood T, Lambert EA, Barton D, Lambert GW. Depressive illness: Biological mechanisms of cardiac risk. Stress and Health 2008;24(3):213-222.
  69. De Silva D, Woon FP, Chen C, Chang HM, Kingwell B, Cameron J, Wong MC. Profile and associations of central pulse wave velocity and central pulse pressure among ischaemic stroke patients. Eur J Neurol 2008;15(2):196-8.
  70. De Silva DA, Woon F-P, Gan H-Y, Cameron JD, Kingwell BA, Koh T-H, Chen C, Chang H-M, Wong M-C. Arterial stiffness, metabolic syndrome and inflammation among Asian ischaemic stroke patients. Eur J Neurol 2008;15(8):872-875.
  71. De Silva DA, Woon FP, Gan HY, Chen C, Chang HM, Cameron J, Kingwell B, Wong MC. Arterial stiffness is associated with raised levels of the inflammatory marker erythrocyte sedimentation rate. Intern Med J 2008;38(12):918-20.
  72. Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med 2008;25(5):523-9.
  73. Di Quinzio MK, Georgiou HM, Holdsworth-Carson SJ, Ayhan M, Heng YJ, Walker SP, Rice GE, Permezel M. Proteomic analysis of human cervico-vaginal fluid displays differential protein expression in association with labor onset at term. J Proteome Res 2008;7(5):1916-21.
  74. Dilley RJ, Little PJ. Another piece of cell biology in the puzzle of inflammation, glucose and diabetic vascular disease. J Hypertens 2008;26(3):396-8. Editorial.
  75. Dimmock DP, Trapane P, Feigenbaum A, Keegan CE, Cederbaum S, Gibson J, Gambello MJ, Vaux K, Ward P, Rice GM, Wolff JA, O'Brien WE, Fang P. The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia. Am J Med Genet A 2008;146A(22):2885-90.
  76. Dinh D, Lee G, Billah B, Smith JA, Shardey GC, Reid C. Trends in coronary artery bypass graft surgery in Victoria, 2001-2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project. Med J Aust 2008;188(4):214-7.
  77. Dixon JB, Hayden MJ, Lambert GW, Dawood T, Anderson ML, Dixon ME, O'Brien PE. Raised CRP levels in obese patients: symptoms of depression have an independent positive association. Obesity 2008;16(9):2010-5.
  78. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299(3):316-23.
  79. Dixon JB, Piterman L, O'Brien PE, Hayden MJ. Physician Attitudes, Beliefs and Barriers towards the Management and Treatment of Adult Obesity: A Literature Review. Aust J Primary Health 2008;14(3):9-18. Review.
  80. Drenckhahn JD, Schwarz QP, Gray S, Laskowski A, Kiriazis H, Ming Z, Harvey RP, Du XJ, Thorburn DR, Cox TC. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development. Dev Cell 2008;15(4):521-33.
  81. Drew BG, Kingwell BA. Acadesine, an adenosine-regulating agent with the potential for widespread indications. Expert Opin Pharmacother 2008;9(12):2137-44. Review.
  82. Driscoll A, Currey J, Worrall-Carter L, Stewart S. Ethical dilemmas of a large national multi-centre study in Australia: time for some consistency. J Clin Nurs 2008;17(16):2212-20.
  83. Du XJ. Distinct role of adrenoceptor subtypes in cardiac adaptation to chronic pressure overload. Clin Exp Pharmacol Physiol 2008;35(3):355-60. Review.
  84. Duffy SJ, Dart AM. Novel cardiac therapies and innocent by standers. Lancet 2008;371(9626):1726-8.
  85. Dunstan DW. Aerobic exercise and resistance training for the management of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008;4(5):250-1. Review.
  86. Eades S, Read AW, Stanley FJ, Eades FN, McCaullay D, Williamson A. Bibbulung Gnarneep ('solid kid'): causal pathways to poor birth outcomes in an urban Aboriginal birth cohort. J Paediatr Child Health 2008;44(6):342-6.
  87. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008;205(10):2409-17.
  88. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118(5):1727-38.
  89. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Dawood T, Kaye D, Barton D, Pier C, Guo L, Brenchley C, Jennings G, Lambert E. Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol 2008;35(4):498-502. Review.
  90. Esler M, Eikelis N, Schlaich M, Lambert G, Alvarenga M, Kaye D, El-Osta A, Guo L, Barton D, Pier C, Brenchley C, Dawood T, Jennings G, Lambert E. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder. Ann N Y Acad Sci 2008;1148:338-48.
  91. Esler MD, Eikelis N, Lambert E, Straznicky N. Neural mechanisms and management of obesity-related hypertension. Curr Cardiol Rep 2008;10(6):456-63.
  92. Esmore D, Kaye D, Spratt P, Larbalestier R, Ruygrok P, Tsui S, Meyers D, Fiane AE, Woodard J. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 2008;27(6):579-88.
  93. Esmore DS, Kaye D, Salamonsen R, Buckland M, Begg JR, Negri J, Ayre P, Woodard J, Rosenfeldt FL. Initial clinical experience with the VentrAssist left ventricular assist device: the pilot trial. J Heart Lung Transplant 2008;27(5):479-85.
  94. Fang L, Gao XM, Samuel CS, Su Y, Lim YL, Dart AM, Du XJ. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction. Clin Sci 2008;115(3):99-106.
  95. Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension. J Cardiovasc Pharmacol 2008;51(6):590-5.
  96. Fitzgerald SM, Srikanth VK, Evans RG, Thrift AG. Benefits and challenges in stroke research in developing countries. Brain Impair 2008;9(2):198-204. Review.
  97. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008;57(6):1446-54. Review.
  98. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51(16):1581-7.
  99. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008;102 (10 Suppl):1K-34K. Review.
  100. Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Zimmet P; Residual Risk Reduction Initiative (R3I). The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res 2008;5(4):319-35. Review.
  101. Fukuda K, Tesch GH, Yap FY, Forbes JM, Flavell RA, Davis RJ, Nikolic-Paterson DJ. MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model. Lab Invest 2008;88(4):398-407.
  102. Fuller M, Rozaklis T, Lovejoy M, Zarrinkalam K, Hopwood JJ, Meikle PJ. Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease. Mol Genet Metab 2008;93(4):437-43.
  103. Gasser A, Forbes JM. Advanced glycation: implications in tissue damage and disease. Protein Pept Lett 2008;15(4):385-91.
  104. Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, Permezel M, Khalil Z, Rice GE. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008;45(3):157-65.
  105. Gicquel C, El-Osta A, Le Bouc Y. Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 2008;22(1):1-16. Review.
  106. Giunti S, Tesch GH, Pinach S, Burt DJ, Cooper ME, Cavallo-Perin P, Camussi G, Gruden G. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008;51:198-207.
  107. Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93(4):1143-52. Review.
  108. Goh SY, Jasik M, Cooper ME. Agents in development for the treatment of diabetic nephropathy. Expert Opin Emerg Drugs 2008;13(3):447-63. Review.
  109. Gomez-Sanchez EP, Romero DG, de Rodriguez AF, Warden MP, Krozowski Z, Gomez-Sanchez CE. Hexose-6-phosphate dehydrogenase and 11 beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology 2008;149(2):525-33.
  110. Gould PA, Esler MD, Kaye DM. Atrial fibrillation is associated with decreased cardiac sympathetic response to isometric exercise in CHF in comparison to sinus rhythm. Pacing Clin Electrophysiol 2008;31(9):1125-9.
  111. Grainger R, Stuckey S, O'Sullivan R, Davis SR, Ebeling PR, Wluka AE. What is the clinical and ethical importance of incidental abnormalities found by knee MRI? Arthritis Res Ther 2008;10(1):R18.
  112. Gregorevic P, Blankinship MJ, Allen JM, Chamberlain JS. Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol Ther 2008;16(4):657-64.
  113. Gregorevic P, Meznarich NA, Blankinship MJ, Crawford RW, Chamberlain JS. Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping. Muscle Nerve 2008;37(1):104-6.
  114. Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 2008;93(5):1834-40.
  115. Grubb DR, Vasilevski O, Huynh H, Woodcock EA. The extreme C-terminal region of phospholipase Cbeta1 determines subcellular localization and function; the "b" splice variant mediates alpha1-adrenergic receptor responses in cardiomyocytes. FASEB J 2008;22(8):2768-74.
  116. Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard JP, Desage M, Skilton MR, Vidal H, Laville M. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr 2008;62(11):1287-93.
  117. Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2008;78(3):546-53.
  118. Hamilton MT, Healy GN, Dunstan DW, Zderic TW, Owen N. Too little exercise and too much sitting: inactivity physiology and the need for new recommendations on sedentary behaviour. Curr Cardiovasc Risk Rep 2008;2(4):292-298.
  119. Hanna FS, Bell RJ, Cicuttini FM, Davison SL, Wluka AE, Davis SR. High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther 2008;10(1):R27.
  120. Haqqani HM, Kalman JM, Kistler PM. Catheter ablation for atrial fibrillation: have we come the full circle? J Cardiovasc Electrophysiol 2008;19(5):480-2. Editorial.
  121. Harikrishnan KN, Karagiannis TC, Chow MZ, El-Osta A. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell Cycle 2008;7(4):468-76.
  122. Hawley JA, Dunstan DW. Overweight and obesity in Australia. Med J Aust 2008;188(11):678; discussion 687-9.
  123. Hawley JA, Dunstan DW. The battle against obesity - attacking physical inactivity as a primary means of defense. Nat Clin Pract Endocrinol Metab 2008;4(10):548-9. Review.
  124. Head GA, Lukoshkova EV. Understanding the morning rise in blood pressure. Clin Exp Pharmacol Physiol 2008;35(4):516-21. Review.
  125. Head GA, Lukoshkova EV, Reid CM. Response to: Analysis and interpretation of 24 hour blood pressure profiles. Am J Hypertens 2008;21(2):127-129. Letter to the editor.
  126. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, Owen N. Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 2008;31(4):661-6.
  127. Healy GN, Dunstan DW, Salmon J, Shaw JE, Zimmet PZ, Owen N. Television time and continuous metabolic risk in physically active adults. Med Sci Sports Exerc 2008;40(4):639-45.
  128. Healy GN, Wijndaele K, Dunstan DW, Shaw JE, Salmon J, Zimmet PZ, Owen N. Objectively-measured sedentary time, physical activity and metabolic risk: the AusDiab study. Diabetes Care 2008;31(2):369-71.
  129. Heng YJ, Di Quinzio MK, Permezel M, Rice GE, Georgiou HM. Interleukin-1 receptor antagonist in human cervicovaginal fluid in term pregnancy and labor. Am J Obstet Gynecol 2008;199(6):656.e1-7.
  130. Hettiarachchi KD, Zimmet PZ, Danial NN, Myers MA. Transplacental exposure to the vacuolar-ATPase inhibitor bafilomycin disrupts survival signaling in beta cells and delays neonatal remodeling of the endocrine pancreas. Exp Toxicol Pathol 2008;60(4-5):295-306.
  131. Hettiarachchi KD, Zimmet PZ, Myers MA. Dietary toxins, endoplasmic reticulum (ER) stress and diabetes. Curr Diabetes Rev 2008;4(2):146-56. Review.
  132. Hoang A, Tefft C, Duffy SJ, Formosa M, Henstridge DC, Kingwell BA, Sviridov D. ABCA1 expression in humans is associated with physical activity and alcohol consumption. Atherosclerosis 2008;197(1):197-203.
  133. Holmes AG, Mesa JL, Neill BA, Chung J, Carey AL, Steinberg GR, Kemp BE, Southgate RJ, Lancaster GI, Bruce CR, Watt MJ, Febbraio MA. Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats. J Endocrinol 2008;198(2):367-74.
  134. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52(19):1574-80.
  135. Inglis SC, Clark RA, Shakib S, Wong DT, Molaee P, Wilkinson D, Stewart S. Hot summers and heart failure: seasonal variations in morbidity and mortality in Australian heart failure patients (1994-2005). Eur J Heart Fail 2008;10(6):540-9.
  136. Irvine JC, Ritchie RH, Favaloro JL, Andrews KL, Widdop RE, Kemp-Harper BK. Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol Sci 2008;29(12):601-8. Review.
  137. Ivey ME, Little PJ. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways. Thromb Res 2008;123(2):288-97.
  138. Ivey ME, Osman N, Little PJ. Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 2008;199(2):237-47. Review.
  139. Janakiramanan N, Teichtahl AJ, Wluka AE, Ding C, Jones G, Davis SR, Cicuttini FM. Static knee alignment is associated with the risk of unicompartmental knee cartilage defects. J Orthop Res 2008;26(2):225-30.
  140. Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008;14(10):979-86. Review.
  141. Jandeleit-Dahm K, Watson A, Soro-Paavonen A. The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Clin Exp Pharmacol Physiol 2008;35(3):329-34. Review.
  142. Januszewski AS, Thomas MC, Karschimkus CS, Chung JS, Rowley KG, Nelson CL, O'Neal DN, Dragicevic G, Harper CA, Best JD, Jenkins AJ. Longitudinal analysis of low-molecular weight fluorophores in Type 1 diabetes mellitus. J Med Invest 2008;55(1-2):29-36.
  143. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 2008;105(18):6531-6.
  144. Joubert J, Joubert L, Reid C, Barton D, Cumming T, Mitchell P, House M, Heng R, Meadows G, Walterfang M, Pantelis C, Ames D, Davis S. The positive effect of integrated care on depressive symptoms in stroke survivors. Cerebrovasc Dis 2008;26(2):199-205.
  145. Kaye DM, Esler MD. Re: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation. J Appl Physiol 2008;104(2):567. Letter to the editor.
  146. Kaye DM, Esler MD. Autonomic control of the aging heart. Neuromolecular Med 2008;10(3):179-86.
  147. Kaye DM, Hoshijima M, Chien KR. Reversing advanced heart failure by targeting Ca2+ cycling. Annu Rev Med 2008;59:13-28. Review.
  148. Kekulawala JR, Murphy A, D'Souza W, Wai C, Chin-Dusting J, Kingwell B, Sviridov D, Mukhamedova N. Impact of freezing on high-density lipoprotein functionality. Anal Biochem 2008;379(2):213-5.
  149. Kiriazis H, Wang K, Xu Q, Gao XM, Ming Z, Su Y, Moore XL, Lambert G, Gibbs ME, Dart AM, Du XJ. Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis. Br J Pharmacol 2008;153(4):684-92.
  150. Kistler PM. Multi electrode ablation for paroxysmal atrial fibrillation: Pulmonary vein isolation made easy? Heart Rhythm 2008;5(12):1643-44. Editorial.
  151. Kistler PM, Rajappan K, Harris S, Earley MJ, Richmond L, Sporton SC, Schilling RJ. Impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J 2008;29(24):3029-36.
  152. Koitka A, Cooper ME, Thomas MC, Tikellis C. Angiotensin converting enzyme 2 in the kidney. Clin Exp Pharmacol Physiol 2008;35(4):420-5. Review.
  153. Koitka A, Tikellis C. Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy. ScientificWorldJournal 2008;8:434-45. Review.
  154. Kondalsamy-Chennakesavan S, Hoy WE, Wang Z, Briganti E, Polkinghorne K, Chadban S, Shaw J; AusDiab Study Group. Anthropometric measurements of Australian Aboriginal adults living in remote areas: comparison with nationally representative findings. Am J Hum Biol 2008;20(3):317-24.
  155. Kondalsamy-Chennakesavan S, Hoy WE, Wang Z, Shaw J. Quantifying the excess risk of Type 2 diabetes by body habitus measurements among Australian Aborigines living in remote areas. Diabetes Care 2008;31(3):585-6.
  156. Kosmala W, Wong C, Kuliczkowska J, Leano R, Przewlocka-Kosmala M, Marwick TH. Use of body weight and insulin resistance to select obese patients for echocardiographic assessment of subclinical left ventricular dysfunction. Am J Cardiol 2008;101(9):1334-40.
  157. Lamb MM, Myers MA, Barriga K, Zimmet PZ, Rewers M, Norris JM. Maternal diet during pregnancy and islet autoimmunity in offspring. Pediatr Diabetes 2008;9(2):135-41.
  158. Lambert E, Dawood T, Schlaich M, Straznicky N, Esler M, Lambert G. Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 2008;35(4):503-7. Review.
  159. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Socratous F, Agrotis A, Jennings G, Lambert G, Vaddadi G. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with the postural tachycardia syndrome. Circ Arrhythmia Electrophysiol 2008;1:103-109.
  160. Larobina ME, Mariani JA, Rowland MA. Aortic valve replacement for aortic stenosis during orthotopic cardiac transplant. Ann Thorac Surg 2008;86(6):1979-82. Commissioned review.
  161. Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, Kim HR, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S; Detect-2 Collaboration. Comparisons of metabolic syndrome definitions in four populations of the Asia-Pacific region. Metab Syndr Relat Disord 2008;6(1):37-46.
  162. Lee CM, Huxley RR, Woodward M, Zimmet P, Shaw J, Cho NH, Kim HR, Viali S, Tominaga M, Vistisen D, Borch-Johnsen K, Colagiuri S; DETECT-2 Collaboration. The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 2008;81(3):377-80.
  163. Lee G. Patient and spouse perceived quality of life five years after coronary artery bypass graft surgery. Open Nurs J 2008;2(5):63-67.
  164. Lee G, Carrington M, Sliwa K, Stewart S. Are ECG abnormalities common in Black Africans with heart failure? Results from the Heart of Soweto Study. SA Heart J 2008;5(1):4-11.
  165. Lee GA. Patients reported health-related quality of life five years post coronary artery bypass graft surgery - a methodological study. Eur J Cardiovasc Nurs 2008;7(1):67-72.
  166. Levinger I, Goodman C, Matthews V, Hare DL, Jerums G, Garnham A, Selig S. BDNF, metabolic risk factors, and resistance training in middle-aged individuals. Med Sci Sports Exerc 2008;40(3):535-41.
  167. Little PJ, Ballinger ML, Burch ML, Osman N. Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process. Open Biochem J 2008;2:135-42.
  168. Little PJ, Ballinger ML, Survase S, Osman N, Ogru E, Geytenbeek S, Bruemmer D, Nigro J. Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis. J Cardiovasc Pharmacol 2008;51(3):274-9.
  169. Little PJ, Drennon KD, Tannock LR. Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP. Arch Physiol Biochem 2008;114(2):120-6.
  170. Little PJ, Ivey ME, Osman N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr Vasc Pharmacol 2008;6(3):195-203.
  171. Little PJ, Osman N, O'Brien KD. Hyperelongated biglycan: the surreptitious initiator of atherosclerosis. Curr Opin Lipidol 2008;19(5):448-54. Review.
  172. MacIsaac RJ, Thomas MC, Panagiotopoulos S, Smith TJ, Hao H, Matthews DG, Jerums G, Burrell LM, Srivastava PM. Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes. Cardiovasc Diabetol 2008;7:15.
  173. Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008;14(10):824-30.
  174. Maeder MT, Kaye DM. B-type natriuretic peptide in end-stage renal disease: a neurohormone rather than a volume status monitor. South Med J 2008;101(11):1081-2.
  175. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S, Jolley D, Owen N, Phillips P, Tapp RJ, Welborn TA, Shaw JE. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2008;31(2):267-72.
  176. Magliano DJ, Shaw JE, Shortreed SM, Nusselder WJ, Liew D, Barr EL, Zimmet PZ, Peeters A. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008;51(12):2179-86.
  177. Malabanan KP, Kanellakis P, Bobik A, Khachigian LM. Activation transcription factor-4 induced by fibroblast growth factor-2 regulates vascular endothelial growth factor-A transcription in vascular smooth muscle cells and mediates intimal thickening in rat arteries following balloon injury. Circ Res 2008;103(4):378-87.
  178. Maple-Brown L, Cunningham J, Dunne K, Whitbread C, Howard D, Weeramanthri T, Tatipata S, Dunbar T, Harper CA, Taylor HR, Zimmet P, O'Dea K, Shaw JE. Complications of diabetes in urban Indigenous Australians: the DRUID study. Diabetes Res Clin Pract 2008;80(3):455-62.
  179. Masuo K, Lambert GW, Rakugi H, Ogihara T, Esler MD. Neurovascular role of sympathetic nervous system and beta- adrenoceptor polymorphisms in obesity and hypertension. Curr Hypertens Rev 2008;4(2):121-30. Review.
  180. Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H, Socratous F, Hastings J, Lambert EA, Ogihara T, Esler MD. Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008;31(6):1093-100.
  181. Matthews VB, Febbraio MA. CNTF: a target therapeutic for obesity-related metabolic disease? J Mol Med 2008;86(4):353-61. Review.
  182. McMullen JR. Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease. Clin Exp Pharmacol Physiol 2008;35(3):349-54. Review.
  183. McRobert EA, Tikoo A, Cooper ME, Bach LA. Localization of the ezrin binding epitope for advanced glycation endproducts. Int J Biochem Cell Biol 2008;40(8):1570-80.
  184. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008;4(5 Suppl):S109-84.
  185. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. Executive summary of the recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic and nonsurgical support of the bariactric patient. Endocr Pract 2008;14(3):318-36.
  186. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric patient. Endocr Pract 2008;14(Suppl 1):1-83.
  187. Meikle PJ, Duplock S, Blacklock D, Whitfield PD, Macintosh G, Hopwood JJ, Fuller M. Effect of lysosomal storage on bis(monoacylglycero)phosphate. Biochem J 2008;411(1):71-8.
  188. Meikle PJ, Whitfield PD, Rozaklis T, Blacklock D, Duplock S, Elstein D, Zimran A, Mengel E, Cannell P, Hopwood JJ, Fuller M. Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention. Blood Cells Mol Dis 2008;40(3):420-7.
  189. Moe KT, Woon FP, De Silva DA, Wong P, Koh TH, Kingwell B, Chin-Dusting J, Wong MC. Association of acute ischemic stroke with the MTHFR C677T polymorphism but not with NOS3 gene polymorphisms in a Singapore population. Eur J Neurol 2008;15(12):1309-14.
  190. Mukhamedova N, Escher G, D'Souza W, Tchoua U, Grant A, Krozowski Z, Bukrinsky M, Sviridov D. Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo. J Lipid Res 2008;49(11):2312-22.
  191. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008;28(11):2071-7.
  192. Myers M, Zimmet P. Halting the accelerating epidemic of Type 1 diabetes. Lancet 2008;371(9626):1730-1. Review.
  193. Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TM. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med 2008;25(10):1245-50.
  194. Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology 2008;109(4):657-63.
  195. Nan H, Qiao Q, Söderberg S, Gao W, Zimmet P, Shaw J, Alberti G, Dong Y, Uusitalo U, Pauvaday V, Chitson P, Tuomilehto J. Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord 2008;6(1):47-57.
  196. Nan H, Qiao Q, Söderberg S, Pitkäniemi J, Zimmet P, Shaw J, Alberti G, Uusitalo U, Pauvaday V, Chitson P, Tuomilehto J. Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 2008;80(2):321-7.
  197. Nelson MR, Reid CM, Ames DA, Beilin LJ, Donnan GA, Gibbs P, Johnston CI, Krum H, Storey E, Tonkin A, Wolfe R, Woods R, McNeil JJ. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study. Med J Aust 2008;189(2):105-9.
  198. Nestel PJ. Effects of dairy fats within different foods on plasma lipids. J Am Coll Nutr 2008;27(6):735S-40S. Review.
  199. Nestel PJ. Editorial. Curr Opin Lipidol 2008;19:1-3. Editorial.
  200. Nestel PJ, O'Brien R, Nelson M. Management of dyslipidaemia - evidence and practical recommendations. Aust Fam Physician 2008;37(7):521-7. Review.
  201. Newman C, Butow P, Knight R, McMillan K, Treloar C, Kippax S, Eades S. Cancer and Aboriginal people in Australia: A review of the literature. Crit Pub Health 2008;18(1):65-75. Review.
  202. Nguyen TT, Wang JJ, Islam FM, Mitchell P, Tapp RJ, Zimmet PZ, Simpson R, Shaw J, Wong TY. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes 2008;57(3):536-9.
  203. Nielsen TC, Meikle PJ, Hopwood JJ, Fuller M. Minimum substrate requirements of endoglycosidase activities toward dermatan sulfate by electrospray ionization-tandem mass spectrometry. Glycobiology 2008;18(12):1119-28.
  204. Nigro J, Potter-Perigo S, Ivey ME, de Dios ST, Evanko SP, Wight TN, Little PJ. The effect of PPAR ligands to modulate glucose metabolism alters the incorporation of metabolic precursors into proteoglycans synthesized by human vascular smooth muscle cells. Arch Physiol Biochem 2008;114(3):171-7.
  205. Nyamdorj R, Qiao Q, Söderberg S, Pitkäniemi J, Zimmet P, Shaw J, Alberti G, Nan H, Uusitalo U, Pauvaday V, Chitson P, Tuomilehto J. Comparison of body mass index with waist circumference, waist-to-hip ratio, and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius. J Hypertens 2008;26(5):866-70.
  206. Obesity in Asia Collaboration, Huxley R, Barzi F, Lee CMY, Janus E, Lam TH, Caterson I, Azizi F, Lear S, Patel J, Shaw J, Adam J, Oh SW, Kang JH, Zimmet P, Woodward M. Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations? J Hypertens 2008;26(2):169-77.
  207. Obesity in Asia Collaboration, Huxley R, James WP, Barzi F, Patel JV, Lear SA, Suriyawongpaisal P, Janus E, Caterson I, Zimmet P, Prabhakaran D, Reddy S, Woodward M. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008;9(suppl 1):53-61. Review.
  208. O'Dea K, Cunningham J, Maple-Brown L, Weeramanthri T, Shaw J, Dunbar T, Zimmet P. Diabetes and cardiovascular risk factors in urban Indigenous adults: results from the DRUID study. Diabetes Res Clin Pract 2008;80(3):483-9.
  209. Odom GL, Gregorevic P, Allen JM, Finn E, Chamberlain JS. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice. Mol Ther 2008;16(9):1539-45.
  210. Ooi EM, Barrett PH, Chan DC, Nestel PJ, Watts GF. Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome. Atherosclerosis 2008;197(1):139-46.
  211. Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome. Asia Pac J Clin Nutr 2008;16(4):624-31.
  212. Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH. Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care 2008;31(8):1656-61.
  213. Ooi EM, Watts GF, Nestel PJ, Sviridov D, Hoang A, Barrett PH. Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome. J Clin Endocrinol Metab 2008;93(2):430-7.
  214. Osman N, Ballinger ML, Dadlani H, Getachew R, Burch ML, Little PJ. p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis. Cardiovasc Hematol Disord Drug Targets 2008;8(4):287-92.
  215. Ott C, Schlaich MP, Harazny J, Schmidt BM, Michelson G, Schmieder RE. Effects of angiotensin II type 1-receptor blockade on retinal endothelial function. J Hypertens 2008;26(3):516-22.
  216. Ott C, Schlaich MP, Schmidt BM, Titze SI, Schäufele T, Schmieder RE. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia. Atherosclerosis 2008;196(2):704-11.
  217. 217.  Parving HH, de Zeeuw D, Cooper ME, Remuzzi G, Liu N, Lunceford J, Shahinfar S, Wong PH, Lyle PA, Rossing P, Brenner BM. ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. J Am Soc Nephrol 2008;19(4):771-9.
  218. 218.  Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P, de Courten B, Yu M, Ravussin E, Gimble JM, Dhurandhar NV. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008;26(4):969-78.
  219. 219.  Payne WR, Walsh KJ, Harvey JT, Livy MF, McKenzie KJ, Donaldson A, Atkinson MG, Keogh JB, Moss RS, Dunstan DW, Hubbard WA. Effect of a low-resource-intensive lifestyle modification program incorporating gymnasium-based and home-based resistance training on type 2 diabetes Risk in Australian Adults. Diabetes Care 2008;31(12):2244-50.
  220. 220.  Pearce DC, Cadilhac DA, Pierce RJ, Thrift AG, David S, Donnan GA; SCOPES II Study Group. Estimating the prevalence of sleep-disordered breathing in community-based, long-term stroke survivors using a validated predictive model. Cerebrovasc Dis 2008;26(4):441-6.
  221. 221.  Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008;88(4):1379-406. Review.
  222. 222.  Peeters A, Magliano DJ, Stevens J, Duncan BB, Klein R, Wong TY. Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 2008;126(11):1554-60.
  223. 223.  Peiris D, Brown A, Cass A. Addressing inequities in access to quality health care for indigenous people. CMAJ 2008;179(10):985-6.
  224. 224.  Pepe S, Leong JY, van der Merwe J, Marasco SF, Hadj A, Lymbury R, Perkins A, Rosenfeldt FL. Targeting oxidative stress in surgery: effects of ageing and therapy. Exp Gerontol 2008;43(7):653-7. Review.
  225. 225.  Percival JM, Anderson KN, Gregorevic P, Chamberlain JS, Froehner SC. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS ONE 2008;3(10):e3387.
  226. 226.  Pfluger HB, Phrommintikul A, Mariani JA, Cherayath JG, Taylor AJ. Utility of myocardial fibrosis and fatty infiltration detected by cardiac magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia-a single centre experience. Heart Lung Circ 2008;17(6):478-83.
  227. 227.  Pretorius L, Owen KL, Jennings GL, McMullen JR. Promoting physiological hypertrophy in the failing heart. Clin Exp Pharmacol Physiol 2008;35(4):438-41. Review.
  228. 228.  Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008;40(5):650-5.
  229. 229.  Rajappan K, Kistler PM, Earley MJ, Thomas G, Izquierdo M, Sporton SC, Schilling RJ. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomical sites. Pacing Clin Electrophysiol 2008;31(12):1598-604.
  230. 230.  Remaley AT, Amar M, Sviridov D. HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications. Expert Rev Cardiovasc Ther 2008;6(9):1203-15.
  231. 231.  Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE. Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 2008;26(7):1427-34.
  232. Roberts-Thomson KC, Stevenson IH, Kistler PM, Haqqani HM, Goldblatt JC, Sanders P, Kalman JM. Anatomically determined functional conduction delay in the posterior left atrium relationship to structural heart disease. J Am Coll Cardiol 2008;51(8):856-62.
  233. Rogers SL, Tikellis G, Cheung N, Tapp R, Shaw J, Zimmet PZ, Mitchell P, Wang JJ, Wong TY. Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008;31(4):761-3.
  234. Rose H, Hoy J, Woolley I, Tchoua U, Bukrinsky M, Dart A, Sviridov D. HIV infection and high density lipoprotein metabolism. Atherosclerosis 2008;199(1):79-86.
  235. Rossignol S, Netchine I, Le Bouc Y, Gicquel C. Epigenetics in Silver-Russell syndrome. Best Pract Res Clin Endocrinol Metab 2008;22(3):403-14. Review.
  236. Rowley KG, O'Dea K, Anderson I, McDermott R, Saraswati K, Tilmouth R, Roberts I, Fitz J, Wang Z, Jenkins A, Best JD, Wang Z, Brown A. Lower than expected morbidity and mortality for an Australian Aboriginal population: 10-year follow-up in a decentralised community. Med J Aust 2008;188(5):283-7.
  237. Ruetens AT, Shaw JE. Experimental and clinical pharmacology - Incretin mimetics and enhancers: clinical applications. Aust Prescr 2008;31(4):104-108.
  238. Salmon J, Dunstan D, Owen N. Should we be concerned about children spending extended periods of time in sedentary pursuits even among the highly active? Int J Pediatr Obes 2008;3(2):66-8.
  239. Schlaich MP, Schmitt D, Ott C, Schmidt BM, Schmieder RE. Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans. J Hypertens 2008;26(1):110-6.
  240. Sethi AA, Stonik JA, Thomas F, Demosky SJ, Amar M, Neufeld E, Brewer HB, Davidson WS, D'Souza W, Sviridov D, Remaley AT. Asymmetry in the lipid affinity of bi-helical amphipathic peptides: a structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides. J Biol Chem 2008;283(47):32273-82.
  241. Shaw J. Obstructive sleep apnoea and type 2 diabetes - the IDF consensus. Diabetes Voice 2008;53(3):29-32. Editorial.
  242. Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE; On behalf of the Melbourne Interventional Group. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovasc Revasc Med 2008;9(4):218-223.
  243. Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, Woollard K, Lyon S, Sviridov D, Dart AM. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res 2008;103(10):1084-91.
  244. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ; International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and Type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008;81(1):2-12.
  245. Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE. Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med 2008;25(3):296-302.
  246. Singh I, Carey AL, Watson N, Febbraio MA, Hawley JA. Oxidative stress-induced insulin resistance in skeletal muscle cells is ameliorated by gamma-tocopherol treatment. Eur J Nutr 2008;47(7):387-92.
  247. Skilton MR. Intrauterine risk factors for precocious atherosclerosis. Pediatrics 2008;121(3):570-4. Review.
  248. Skilton MR, Laville M, Cust AE, Moulin P, Bonnet F. The association between dietary macronutrient intake and the prevalence of the metabolic syndrome. Br J Nutr 2008;100(2):400-7.
  249. Skilton MR, Sieveking DP, Harmer JA, Franklin J, Loughnan G, Nakhla S, Sullivan DR, Caterson ID, Celermajer DS. The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes Obes Metab 2008;10(10):874-84.
  250. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371(9616):915-22.
  251. Smyth I, Hacking DF, Hilton AA, Mukhamedova N, Meikle PJ, Ellis S, Slattery K, Collinge JE, de Graaf CA, Bahlo M, Sviridov D, Kile BT, Hilton DJ. A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet 2008;4(9):e1000192.
  252. Soldatos G, Cooper ME. Diabetic nephropathy: important pathophysiologic mechanisms. Diabetes Res Clin Pract 2008;82(Suppl 1):S75-9. Review.
  253. Soon PS, Libe R, Benn DE, Gill A, Shaw J, Sywak MS, Groussin L, Bertagna X, Gicquel C, Bertherat J, McDonald KL, Sidhu SB, Robinson BG. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Ann Surg 2008;247(1):157-64.
  254. Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008;57(9):2461-9.
  255. Sourris KC, Forbes JM, Cooper ME. Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome? Ann N Y Acad Sci 2008;1126:101-6. Review.
  256. Srivastava PM, Calafiore P, Macisaac RJ, Patel SK, Thomas MC, Jerums G, Burrell LM. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci 2008;114(4):313-20.
  257. Stewart S. Beyond the numbers: the individual challenges of combating consistently poor survival in heart failure. Am Heart J 2008;155(2):195-6. Editorial.
  258. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K. Predominance of heart failure in the Heart of Soweto Study Cohort. Emerging challenges for urban African communities. Circulation 2008;118(23):2360-7.
  259. Straub A, Wendel HP, Dietz K, Schiebold D, Peter K, Schoenwaelder SM, Ziemer G. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation. Thromb Haemost 2008;99(3):609-15.
  260. Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008;10(6):440-7. Review.
  261. Sugiyama T, Healy GN, Dunstan DW, Salmon J, Owen N. Joint associations of multiple leisure-time sedentary behaviours and physical activity with obesity in Australian adults. Int J Behav Nutr Phys Act 2008;5:35.
  262. Sugiyama T, Healy GN, Dunstan DW, Salmon J, Owen N. Is television viewing time a marker of a broader pattern of sedentary behavior? Ann Behav Med 2008;35(2):245-50.
  263. Sviridov D, Hoang A, Ooi E, Watts G, Barrett PH, Nestel P. Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. Atherosclerosis 2008;197(2):732-9.
  264. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 2008;15(2):52-62.
  265. Sviridov D, Nestel P, Watts G. Statins and metabolism of high density lipoprotein. Cardiovasc Hematol Agents Med Chem 2008;5(3):215-21. Review.
  266. Szollosi I, Thompson BR, Krum H, Kaye DM, Naughton MT. Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest 2008;134(1):67-72.
  267. Tan MA, Dean CJ, Hopwood JJ, Meikle PJ. Diagnosis of metachromatic leukodystrophy by immune quantification of arylsulphatase A protein and activity in dried blood spots. Clin Chem 2008;54(11):1925-7.
  268. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE; Australian Diabetes Obesity and Lifestyle Study Group. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008;31(7):1349-54.
  269. Tay-Teo K, Moodie M, Bernhardt J, Thrift AG, Collier J, Donnan G, Dewey H. Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT). Cerebrovasc Dis 2008;26(5):457-81.
  270. Tchoua U, D'Souza W, Mukhamedova N, Blum D, Niesor E, Mizrahi J, Maugeais C, Sviridov D. The effect of cholesteryl ester transport protein overexpression and inhibition on reverse cholesterol transport. Cardiovasc Res 2008;77(4):732-9.
  271. Teichtahl AJ, Wang Y, Wluka AE, Cicuttini FM. Obesity and knee osteoarthritis: new insights provided by body composition studies. Obesity 2008;16(2):232-40. Review.
  272. Teichtahl AJ, Wang Y, Wluka AE, Szramka M, English DR, Giles GG, O'Sullivan R, Cicuttini FM. The longitudinal relationship between body composition and patella cartilage in healthy adults. Obesity 2008;16(2):421-7.
  273. Tejero ME, Voruganti VS, Proffitt JM, Curran JE, Göring HH, Johnson MP, Dyer TD, Jowett JB, Collier GR, Moses EK, MacCluer JW, Mahaney MC, Blangero J, Comuzzie AG, Cole SA. Cross-species replication of a resistin mRNA QTL, but not QTLs for circulating levels of resistin, in human and baboon. Heredity 2008;101(1):60-6.
  274. Tershakovec AM, Keane WF, Zhang Z, Lyle PA, Appel GB, McGill JB, Parving HH, Cooper ME, Shahinfar S, Brenner BM. Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study. Diabetes Care 2008;31(3):445-7.
  275. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris K, Penfold S, Bach LA, Cooper ME, Forbes JM. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008;57(2):460-9.
  276. Thomas MC. The assessment and management of albuminuria in primary care. Diabetes Res Clin Pract 2008;80(1):83-8.
  277. Thomas MC, Viberti G, Groop PH. Screening for chronic kidney disease in patients with diabetes: are we missing the point? Nat Clin Pract Nephrol 2008;4(1):2-3. Review.
  278. Thompson DR, Stewart S. Chronic cardiovascular disease management: how can it be improved? Eur J Cardiovasc Prev Rehabil 2008;15(1):1-2. Editorial.
  279. Thrift AG, Srikanth VK. Risk factors for dementia. Neuroepidemiology 2008;31(1):68.
  280. Tikellis C, Bialkowski K, Pete J, Sheehy K, Su Q, Johnston C, Cooper ME, Thomas MC. ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008;57(4):1018-25.
  281. Tikellis C, Jandeleit-Dahm KA, Sheehy K, Murphy A, Chin-Dusting J, Kling D, Sebokova E, Cooper ME, Mizrahi J, Woollard KJ. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules. Atherosclerosis 2008;199(1):55-64.
  282. Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, Bialkowski K, Tan A, Bierhaus A, Cooper ME, Forbes JM. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 2008;295(2):E323-30.
  283. Tilbrook AJ, Rivalland EA, Turner AI, Lambert GW, Clarke IJ. Responses of the hypothalamopituitary adrenal axis and the sympathoadrenal system to isolation/restraint stress in sheep of different adiposity. Neuroendocrinology 2008;87(4):193-205.
  284. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I; Australian Ovarian Cancer Study Group, Gertig D, DeFazio A, Bowtell DD. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008;14(16):5198-208.
  285. Urquhart DM, Hanna F, Graves S, Wang Y, Cameron P, Hannaford A, Cicuttini FM. In-hospital outcomes and hospital resource utilization of hip replacement procedures. ANZ J Surg 2008;78(10):875-80.
  286. Urquhart DM, Soufan C, Teichtahl AJ, Wluka AE, Hanna F, Cicuttini FM. Factors that may mediate the relationship between physical activity and the risk for developing knee osteoarthritis. Arthritis Res Ther 2008;10(1):203. Review.
  287. Vasilevski O, Grubb DR, Filtz TM, Yang S, McLeod-Dryden TJ, Luo J, Karna D, Chen J, Woodcock EA. Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes. J Mol Cell Cardiol 2008;45(5):679-84.
  288. von Zur Muhlen C, Sibson NR, Peter K, Campbell SJ, Wilainam P, Grau GE, Bode C, Choudhury RP, Anthony DC. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 2008;118(3):1198-207.
  289. von Zur Muhlen C, von Elverfeldt D, Choudhury RP, Ender J, Ahrens I, Schwarz M, Hennig J, Bode C, Peter K. Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths. Mol Imaging 2008;7(2):59-67.
  290. von zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008;118(3):258-67.
  291. Walker F, Zhang HH, Matthews V, Weinstock J, Nice EC, Ernst M, Rose-John S, Burgess AW. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 2008;111(8):3978-85.
  292. Walker KZ, Woods JL, Rickard CA, Wong CK. Product variety in Australian snacks and drinks: how can the consumer make a healthy choice? Public Health Nutr 2008;11(10):1046-53.
  293. Walsh W, Brown A, Carapetis J; RF/RHD Guideline Development Working Group; National Heart Foundation of Australia; Cardiac Society of Australia and New Zealand. The diagnosis and management of chronic rheumatic heart disease - an Australian guideline. Heart Lung Circ 2008;17(4):271-89. Review.
  294. Wand AP, Eades SJ. Navigating the process of developing a research project in Aboriginal health. Med J Aust 2008;188(10):584-7. Review.
  295. Watt MJ, van Denderen BJ, Castelli LA, Bruce CR, Hoy AJ, Kraegen EW, Macaulay L, Kemp BE. Adipose triglyceride lipase regulation of skeletal muscle lipid metabolism and insulin responsiveness. Mol Endocrinol 2008;22(5):1200-12.
  296. West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; LIPID Study Investigators. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. Eur Heart J 2008;29(7):923-31.
  297. White AJ, Kedia G, Mirocha JM, Lee MS, Forrester JS, Morales WC, Dohad S, Kar S, Czer LS, Fontana GP, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. JACC Cardiovasc Interv 2008;1(3):236-45.
  298. White SL, Polkinghorne KR, Cass A, Shaw J, Atkins RC, Chadban SJ. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008;188(4):204-8.
  299. Wijayaratne SP, Teichtahl AJ, Wluka AE, Hanna F, Bell R, Davis SR, Adams J, Cicuttini FM. The determinants of change in patella cartilage volume - a cohort study of healthy middle-aged women. Rheumatology 2008;47(9):1426-9.
  300. Wluka AE, Wang Y, Davies-Tuck M, English DR, Giles GG, Cicuttini FM. Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs. Rheumatology 2008;47(9):1392-6.
  301. Wong TY, Liew G, Tapp RJ, Schmidt MI, Wang JJ, Mitchell P, Klein R, Klein BE, Zimmet P, Shaw J. Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008;371(9614):736-43.
  302. Wood L, France K, Hunt K, Eades S, Slack-Smith L. Indigenous women and smoking during pregnancy: knowledge, cultural contexts and barriers to cessation. Soc Sci Med 2008;66(11):2378-89.
  303. Woodcock EA, Du XJ, Reichelt ME, Graham RM. Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc Res 2008;77(3):452-62.
  304. Woodman OL, Malakul W, Cao AH, Xu Q, Ritchie RH. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction. Life Sci 2008;82(15-16):847-54.
  305. Woollard KJ, Suhartoyo A, Harris EE, Eisenhardt SU, Jackson SP, Peter K, Dart AM, Hickey MJ, Chin-Dusting JP. Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res 2008;103(10):1128-38.
  306. Xu Q, Lekgabe ED, Gao XM, Ming Z, Tregear GW, Dart AM, Bathgate RA, Samuel CS, Du XJ. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Endocrinology 2008;149(2):476-82.
  307. Yan BP, Ajani AE, New G, Duffy SJ, Farouque O, Shaw J, Sebastian M, Lew R, Brennan A, Andrianopoulos N, Reid C, Clark DJ; Melbourne Interventional Group Investigators. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry. Int J Cardiol 2008;130(3):374-9.
  308. Yan BP, Duffy SJ, Clark DJ, Lefkovits J, Warren R, Gurvitch R, Lew R, Sebastian M, Brennan A, Andrianopoulos N, Reid CM, Ajani AE; Melbourne Interventional Group. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry). Am J Cardiol 2008;101(12):1716-22.
  309. Yang Y, Ma Y, Han W, Li J, Xiang Y, Liu F, Ma X, Zhang J, Fu Z, Su YD, Du XJ, Gao XM. Age-related differences in postinfarct left ventricular rupture and remodeling. Am J Physiol Heart Circ Physiol 2008;294(4):H1815-22.
  310. Zhang WZ, Venardos K, Finch S, Kaye DM. Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation. Int J Biochem Cell Biol 2008;40(5):920-8.
  311. Zimmerli LU, Schiffer E, Zürbig P, Good DM, Kellmann M, Mouls L, Pitt AR, Coon JJ, Schmieder RE, Peter K, Mischak H, Kolch W, Delles C, Dominiczak AF. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 2008;7(2):290-8.
  312. Zimmet P, Alberti G. The metabolic syndrome: progress towards one definition for an epidemic of our time. Nat Clin Pract Endocrinol Metab 2008;4(5):239. Editorial.

Book chapters

  1. Barr ELM, Zimmet P, Shaw JE. Mortality and Life Expectancy Associated with Diabetes. In: Ekoe J-M, Rewers M, Williams R, Zimmet P (eds). The Epidemiology of Diabetes Mellitus 2nd Edition, John Wiley & Sons Ltd, Chichester 2008;Chapter 36:603-625.
  2. Bourne AM, Thomas WG. ADAMs as mediators of angiotensin II actions. In: Leung PS (ed) Proteases in Biology and Disease, Vol 7, Frontiers in Research of the Renin-Angiotensin System on Human Disease. Springer 2008;Chapter 13:273-301.
  3. Brownlee M, Aiello LP, Cooper ME, Vinik AI, Nesto R, Boulton AJM. Complications of diabetes mellitus. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams Textbook of Endocrinology, 11th edn. W.B. Saunders, Philadelphia 2008;Chapter 32.
  4. Cooper ME, Brownlee M. Reducing the Burden of Diabetic Vascular Complications. In: Greenbaum CJ, Harrison LC (eds) Diabetes: Translating Research Into Practice, Informa Health Care USA Inc New York 2008;Chapter 9:159-73.
  5. Dawood T, Lambert GW. Depression as a risk factor for the development of heart disease. In: Sher L (Ed). Psychological Factors and Cardiovascular Disorders: The Role of Psychiatric Pathology and Maladaptive Personality Features, Nova Science Publishers Inc, New York 2008;Chapter 3:31-44.
  6. Ekoé J-M, Zimmet PZ. Diagnosis and Classification. In: Ekoe J-M, Rewers M, Williams R, Zimmet P (eds). The Epidemiology of Diabetes Mellitus 2nd Edition, John Wiley & Sons Ltd, Chichester 2008;Chapter 3:11-30.
  7. Ekoé J-M, Zimmet PZ, Yale J-F. The Clinical Syndrome and the Biochemical Definition. In: Ekoe J-M, Rewers M, Williams R, Zimmet P (eds). The Epidemiology of Diabetes Mellitus 2nd Edition, John Wiley & Sons Ltd, Chichester 2008;Chapter 2:5-9.
  8. Magliano DJ, Cameron J, Shaw JE, Zimmet PZ. Epidemiology of Metabolic Syndrome. In: Ekoe J-M, Rewers M, Williams R, Zimmet P (eds). The Epidemiology of Diabetes Mellitus 2nd Edition, John Wiley & Sons Ltd, Chichester 2008;Chapter 4:31-55.
  9. Masuo K, Lambert GW, Esler MD. Does epinephrine cause hypertension? - Epinephrine hypothesis. In: Lawson AG, Gorman RI (eds). Research Progress on Epinephrine, Nova Science Publishers, New York 2008;Chapter 5:95-114.
  10. Masuo K, Straznicky N, Esler MD. Obesity and obesity-related hypertension: role of the sympathetic nervous system and beta-adrenoreceptor polymorphisms. In: Kaneko M (ed) Sympathetic Nervous System Research Developments, Nova Science Publishers, USA 2008;Chapter 2:67-92.
  11. Pattenden LK, Thomas WG. Amylose affinity chromatography of maltose-binding protein: purification by both native and novel matrix-assisted dialysis-refolding methods. In: Zachariou M (ed) Methods in Molecular Biology, Vol 421, Affinity Chromatography: Methods and Protocols, 2nd edition. Chapter 12. Humana Press, USA 2008;421:169-89.
  12. Paul SL, Thrift AG. The Epidemiology of Stroke in Women. In: Cadolotti JT, Burnside JE (Eds). Women and Stroke Research, Nova Science Publishers, New York 2008;Chapter 2:25-56.
  13. Shaw JE, Dabelea DM. Epidemiology of Type 2 Diabetes in Children and Adolescents. In: Ekoe J-M, Rewers M, Williams R, Zimmet P (eds) The Epidemiology of Diabetes Mellitus 2nd Edition, John Wiley & Sons Ltd, Chichester 2008;339-353.
  14. Shaw JE, Sicree R. Epidemiology of Type 2 Diabetes. In: Feinglos MN, Bethel MA (eds). Type 2 Diabetes Mellitus. An Evidence-Based Approach to Practical Management. Human Press, New Jersey 2008;Chapter 1:1-16.
  15. Straznicky NE, Nestel PJ, Esler MD. Autonomic nervous control of metabolic function. In: Squire LR (ed) Encyclopaedia of Neuroscience. Elsevier, Academic Press 2008;
  16. Sturm JW, Mackay MT, Thrift AG. Stroke among women, ethnic groups, young adults, and children. In: Fisher M (ed) Handbook of Clinical Neurology, Vol 92 (Stroke Part I: Basic and Epidemiological Aspects). Elsevier 2008;92:337-53.
  17. Zimmet P, Kerr-Bayles L, Walder K, Jowett J. Diabetes and cardiovascular medicine: epidemiological environmental and molecular contributions. In: Opie LH, Yellon DM (eds) Cardiology at the Limits X. Stanford Writers, South Africa 2008;CATLx:89-102.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more